Calamos Advisors
BMEZ icon

Calamos Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Calamos Advisors’s Portfolio BMEZ Stock Details BMEZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$848K Buy
55,243
+3,684
+7% +$53K ﹤0.01% 773
2026
Q1 		$740K Buy
+51,559
New +$766K ﹤0.01% 844

Other funds holding BMEZ

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Calamos Advisors's BMEZ Position: Q2 2026 in Review

Calamos Advisors increased its BlackRock Health Sciences Trust II (BMEZ) stake by 7.1% in Q2 2026, buying an estimated $53K and bringing the position to 55,243 shares worth $848K. The position accounts for ﹤0.01% of the portfolio, ranked #773.

Calamos Advisors first reported a position in BMEZ in Q1 2026 and has held it in 2 quarters since. 89 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

  • Calamos Advisors held 55,243 shares of BlackRock Health Sciences Trust II worth $848K as of Q2 2026.
  • Calamos Advisors bought 3,684 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $53K.
  • BlackRock Health Sciences Trust II made up ﹤0.01% of Calamos Advisors's portfolio in Q2 2026, its #773 holding.
  • Calamos Advisors first reported a position in BlackRock Health Sciences Trust II in Q1 2026 and has held it in 2 quarters since.
  • 89 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.